200 related articles for article (PubMed ID: 26968460)
1. Zebrafish Tg(hb9:MTS-Kaede): a new in vivo tool for studying the axonal movement of mitochondria.
Bergamin G; Cieri D; Vazza G; Argenton F; Mostacciuolo ML
Biochim Biophys Acta; 2016 Jun; 1860(6):1247-55. PubMed ID: 26968460
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial dynamics and inherited peripheral nerve diseases.
Pareyson D; Saveri P; Sagnelli A; Piscosquito G
Neurosci Lett; 2015 Jun; 596():66-77. PubMed ID: 25847151
[TBL] [Abstract][Full Text] [Related]
3. Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations.
Baloh RH; Schmidt RE; Pestronk A; Milbrandt J
J Neurosci; 2007 Jan; 27(2):422-30. PubMed ID: 17215403
[TBL] [Abstract][Full Text] [Related]
4. Expression of mitofusin 2(R94Q) in a transgenic mouse leads to Charcot-Marie-Tooth neuropathy type 2A.
Cartoni R; Arnaud E; Médard JJ; Poirot O; Courvoisier DS; Chrast R; Martinou JC
Brain; 2010 May; 133(Pt 5):1460-9. PubMed ID: 20418531
[TBL] [Abstract][Full Text] [Related]
5. The Charcot-Marie Tooth Disease Mutation R94Q in MFN2 Decreases ATP Production but Increases Mitochondrial Respiration under Conditions of Mild Oxidative Stress.
Wolf C; Zimmermann R; Thaher O; Bueno D; Wüllner V; Schäfer MKE; Albrecht P; Methner A
Cells; 2019 Oct; 8(10):. PubMed ID: 31640251
[TBL] [Abstract][Full Text] [Related]
6. Axonal Transport Defects in a Mitofusin 2 Loss of Function Model of Charcot-Marie-Tooth Disease in Zebrafish.
Chapman AL; Bennett EJ; Ramesh TM; De Vos KJ; Grierson AJ
PLoS One; 2013; 8(6):e67276. PubMed ID: 23840650
[TBL] [Abstract][Full Text] [Related]
7. Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex.
Misko A; Jiang S; Wegorzewska I; Milbrandt J; Baloh RH
J Neurosci; 2010 Mar; 30(12):4232-40. PubMed ID: 20335458
[TBL] [Abstract][Full Text] [Related]
8. Axonal Charcot-Marie-Tooth disease patient-derived motor neurons demonstrate disease-specific phenotypes including abnormal electrophysiological properties.
Saporta MA; Dang V; Volfson D; Zou B; Xie XS; Adebola A; Liem RK; Shy M; Dimos JT
Exp Neurol; 2015 Jan; 263():190-9. PubMed ID: 25448007
[TBL] [Abstract][Full Text] [Related]
9. Hindlimb gait defects due to motor axon loss and reduced distal muscles in a transgenic mouse model of Charcot-Marie-Tooth type 2A.
Detmer SA; Vande Velde C; Cleveland DW; Chan DC
Hum Mol Genet; 2008 Feb; 17(3):367-75. PubMed ID: 17959936
[TBL] [Abstract][Full Text] [Related]
10. Bioenergetic defect associated with mKATP channel opening in a mouse model carrying a mitofusin 2 mutation.
Guillet V; Gueguen N; Cartoni R; Chevrollier A; Desquiret V; Angebault C; Amati-Bonneau P; Procaccio V; Bonneau D; Martinou JC; Reynier P
FASEB J; 2011 May; 25(5):1618-27. PubMed ID: 21285398
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial deficits and abnormal mitochondrial retrograde axonal transport play a role in the pathogenesis of mutant Hsp27-induced Charcot Marie Tooth Disease.
Kalmar B; Innes A; Wanisch K; Kolaszynska AK; Pandraud A; Kelly G; Abramov AY; Reilly MM; Schiavo G; Greensmith L
Hum Mol Genet; 2017 Sep; 26(17):3313-3326. PubMed ID: 28595321
[TBL] [Abstract][Full Text] [Related]
12. Burst mitofusin activation reverses neuromuscular dysfunction in murine CMT2A.
Franco A; Dang X; Walton EK; Ho JN; Zablocka B; Ly C; Miller TM; Baloh RH; Shy ME; Yoo AS; Dorn GW
Elife; 2020 Oct; 9():. PubMed ID: 33074106
[TBL] [Abstract][Full Text] [Related]
13. Role of mitofusin 2 mutations in the physiopathology of Charcot-Marie-Tooth disease type 2A.
Cartoni R; Martinou JC
Exp Neurol; 2009 Aug; 218(2):268-73. PubMed ID: 19427854
[TBL] [Abstract][Full Text] [Related]
14. Normal role of the low-molecular-weight neurofilament protein in mitochondrial dynamics and disruption in Charcot-Marie-Tooth disease.
Gentil BJ; Minotti S; Beange M; Baloh RH; Julien JP; Durham HD
FASEB J; 2012 Mar; 26(3):1194-203. PubMed ID: 22155564
[TBL] [Abstract][Full Text] [Related]
15. Developmental defects and neuromuscular alterations due to mitofusin 2 gene (MFN2) silencing in zebrafish: a new model for Charcot-Marie-Tooth type 2A neuropathy.
Vettori A; Bergamin G; Moro E; Vazza G; Polo G; Tiso N; Argenton F; Mostacciuolo ML
Neuromuscul Disord; 2011 Jan; 21(1):58-67. PubMed ID: 20951042
[TBL] [Abstract][Full Text] [Related]
16. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the mitofusin 2 R94W mutation in a knock-in mouse model.
Strickland AV; Rebelo AP; Zhang F; Price J; Bolon B; Silva JP; Wen R; Züchner S
J Peripher Nerv Syst; 2014 Jun; 19(2):152-64. PubMed ID: 24862862
[TBL] [Abstract][Full Text] [Related]
18. [Mutations in the mitofusin 2 gene are the most common cause of Charcot-Marie-Tooth type 2 disease].
Sołtysińska E; Kabzińska D; Kochański A
Neurol Neurochir Pol; 2007; 41(4):350-4. PubMed ID: 17874344
[TBL] [Abstract][Full Text] [Related]
19. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations.
Chung KW; Kim SB; Park KD; Choi KG; Lee JH; Eun HW; Suh JS; Hwang JH; Kim WK; Seo BC; Kim SH; Son IH; Kim SM; Sunwoo IN; Choi BO
Brain; 2006 Aug; 129(Pt 8):2103-18. PubMed ID: 16835246
[TBL] [Abstract][Full Text] [Related]
20. Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutations.
Detmer SA; Chan DC
J Cell Biol; 2007 Feb; 176(4):405-14. PubMed ID: 17296794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
